# Avidbank Holdings, Inc.: financial statements, quarterly

AVBH · Nasdaq · CIK 1443575 · [Financials](/sectors/financials.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/avbh.md) · [Financials](/companies/avbh/financials.md) · [Filings](/companies/avbh/filings.md) · [Insiders](/companies/avbh/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/avbh/financials.md?period=annual).

## Income statement

| Line item | Unit | period not labelled (2024-06-30) | period not labelled (2024-09-30) | period not labelled (2024-12-31) | period not labelled (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [1.1](/filings/0001443575-25-000006.md) | [1.8](/filings/0001443575-25-000051.md) | not reported | [0.0](/filings/0001437749-26-016715.md) | [1.5](/filings/0001443575-25-000006.md) | [(60.9)](/filings/0001443575-25-000051.md) | not reported | [0.1](/filings/0001437749-26-016715.md) | not reported |
| Income tax | $m | [1.4](/filings/0001443575-25-000006.md) | [2.5](/filings/0001443575-25-000051.md) | [2.8 d](/filings/0001437749-26-008852.md) | [2.2](/filings/0001437749-26-016715.md) | [2.5](/filings/0001437749-26-027372.md) | [(15.3)](/filings/0001443575-25-000051.md) | [3.1 d](/filings/0001437749-26-008852.md) | [3.4](/filings/0001437749-26-016715.md) | [2.8](/filings/0001437749-26-027372.md) |
| Net income | $m | [3.5](/filings/0001443575-25-000006.md) | [5.8](/filings/0001443575-25-000051.md) | [6.5 d](/filings/0001437749-26-008852.md) | [5.4](/filings/0001437749-26-016715.md) | [5.8](/filings/0001437749-26-027372.md) | [(37.7)](/filings/0001443575-25-000051.md) | [6.9 d](/filings/0001437749-26-008852.md) | [9.0](/filings/0001437749-26-016715.md) | [7.6](/filings/0001437749-26-027372.md) |
| Diluted EPS | $ per share | [0.46](/filings/0001443575-25-000006.md) | [0.77](/filings/0001443575-25-000051.md) | not reported | [0.71](/filings/0001437749-26-016715.md) | [0.75](/filings/0001437749-26-027372.md) | [(4.12)](/filings/0001443575-25-000051.md) | not reported | [0.84](/filings/0001437749-26-016715.md) | [0.71](/filings/0001437749-26-027372.md) |
| Basic EPS | $ per share | [0.47](/filings/0001443575-25-000006.md) | [0.79](/filings/0001443575-25-000051.md) | not reported | [0.73](/filings/0001437749-26-016715.md) | [0.77](/filings/0001437749-26-027372.md) | [(4.12)](/filings/0001443575-25-000051.md) | not reported | [0.85](/filings/0001437749-26-016715.md) | [0.72](/filings/0001437749-26-027372.md) |

- Revenue: us-gaap:Revenues, us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | period not labelled (2023-12-31) | period not labelled (2024-03-31) | period not labelled (2024-06-30) | period not labelled (2024-09-30) | period not labelled (2024-12-31) | period not labelled (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | not reported | not reported | not reported | not reported | [82.7](/filings/0001437749-26-008852.md) | not reported | not reported | not reported | [155](/filings/0001437749-26-027372.md) | [149](/filings/0001437749-26-016715.md) | [160](/filings/0001437749-26-027372.md) |
| Total assets | $m | not reported | not reported | not reported | not reported | [2,304](/filings/0001437749-26-008852.md) | not reported | [2,392](/filings/0001443575-25-000006.md) | [2,362](/filings/0001443575-25-000051.md) | [2,570](/filings/0001437749-26-027372.md) | [2,580](/filings/0001437749-26-016715.md) | [2,660](/filings/0001437749-26-027372.md) |
| Total liabilities | $m | not reported | not reported | not reported | not reported | [2,118](/filings/0001437749-26-008852.md) | not reported | [2,188](/filings/0001443575-25-000006.md) | [2,089](/filings/0001443575-25-000051.md) | [2,289](/filings/0001437749-26-027372.md) | [2,291](/filings/0001437749-26-016715.md) | [2,364](/filings/0001437749-26-027372.md) |
| Short-term borrowings | $m | not reported | not reported | not reported | not reported | [185](/filings/0001437749-26-008852.md) | not reported | [145](/filings/0001443575-25-000006.md) | not reported | [60.0](/filings/0001437749-26-027372.md) | [55.0](/filings/0001437749-26-016715.md) | [0.0](/filings/0001437749-26-027372.md) |
| Shareholders' equity | $m | [165](/filings/0001437749-26-008852.md) | [167](/filings/0001443575-25-000006.md) | [171](/filings/0001443575-25-000051.md) | [189](/filings/0001443575-25-000051.md) | [186](/filings/0001437749-26-027372.md) | [197](/filings/0001437749-26-027372.md) | [204](/filings/0001437749-26-027372.md) | [273](/filings/0001443575-25-000051.md) | [281](/filings/0001437749-26-027372.md) | [288](/filings/0001437749-26-027372.md) | [296](/filings/0001437749-26-027372.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Total assets: us-gaap:Assets
- Total liabilities: us-gaap:Liabilities
- Short-term borrowings: us-gaap:ShortTermBorrowings
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | period not labelled (2024-09-30) | period not labelled (2024-12-31) | period not labelled (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [5.6 d](/filings/0001443575-25-000051.md) | [7.1 d](/filings/0001437749-26-008852.md) | [4.3](/filings/0001437749-26-016715.md) | [6.4 d](/filings/0001437749-26-027372.md) | [12.4 d](/filings/0001443575-25-000051.md) | [16.0 d](/filings/0001437749-26-008852.md) | [8.2](/filings/0001437749-26-016715.md) | [15.9 d](/filings/0001437749-26-027372.md) |
| Capital expenditure | $m | [(0.0) d](/filings/0001443575-25-000051.md) | [0.0 d](/filings/0001437749-26-008852.md) | [0.0](/filings/0001437749-26-016715.md) | [0.0 d](/filings/0001437749-26-027372.md) | [0.0 d](/filings/0001443575-25-000051.md) | [0.0 d](/filings/0001437749-26-008852.md) | [0.0](/filings/0001437749-26-016715.md) | [0.0 d](/filings/0001437749-26-027372.md) |
| Share repurchases | $m | not reported | not reported | [0.0](/filings/0001437749-26-016715.md) | [0.0 d](/filings/0001437749-26-027372.md) | not reported | not reported | [0.7](/filings/0001437749-26-016715.md) | [0.0 d](/filings/0001437749-26-027372.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
- Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock

## Shares

| Line item | Unit | period not labelled (2024-06-30) | period not labelled (2024-09-30) | period not labelled (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [7.6](/filings/0001443575-25-000006.md) | [7.6](/filings/0001443575-25-000051.md) | [7.7](/filings/0001437749-26-016715.md) | [7.7](/filings/0001437749-26-027372.md) | [9.2](/filings/0001443575-25-000051.md) | [10.8](/filings/0001437749-26-016715.md) | [10.8](/filings/0001437749-26-027372.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 10,983,480 at 2026-07-31, from the cover of the [10-Q filed 2026-08-12](/filings/0001437749-26-027372.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:40 ET. No prices; not investment advice.